Fulvestrant: prices and alternatives
Fulvestrant is an estrogen receptor antagonist indicated for hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women, either as initial endocrine-based therapy or following disease progression on prior endocrine therapy. It may be used in combination with CDK4/6 inhibitors such as…
3 products with this active ingredient from 3 manufacturers. Official prices from 6270 to 10330 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.